Lili Su

1PUBLICATIONS
1CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Jun 09, 2025
Cost-utility analysis of osimertinib and dacomitinib in the first-line treatment of advanced non-small cell lung cancer with EGFR mutation.

Lili Su, Xiangyu Zhang, Mengrong Li

Pageof 1

Frequent Collaborators

1 joint publications

Mengrong Li